Ningbo Menovo Pharmaceutical CoSHSE:603538 +10.00%62 Dividend Yield % is 0.14% as of Jul. 02, 2026, which is 79% below its 10-year median of 0.68. GuruFocus rates SHSE:603538 with a GF Score™ of 62/100 and a GF Value™ of ¥22.23 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 516 Drug Manufacturers companies, Ningbo Menovo Pharmaceutical Co ranks worse than 95.93% on this metric.
The historical rank and industry rank for Ningbo Menovo Pharmaceutical Co's Dividend Yield % or its related term are showing as below:
SHSE:603538'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.08 Med: 0.68 Max: 1.48
Current: 0.14
During the past 13 years, the highest Dividend Yield of Ningbo Menovo Pharmaceutical Co was 1.48%. The lowest was 0.08%. And the median was 0.68%.
SHSE:603538's Dividend Yield % is ranked worse than 95.93% of 516
companies
in the Drug Manufacturers industry
Industry Median: 1.965
vs SHSE:603538: 0.14
During the past 12 months, Ningbo Menovo Pharmaceutical Co's average Dividends Per Share Growth Rate was 150.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -36.90% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Ningbo Menovo Pharmaceutical Co was 27.80% per year. The lowest was -36.90% per year. And the median was 11.60% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Ningbo Menovo Pharmaceutical Co (SHSE:603538) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ningbo Menovo Pharmaceutical Co Dividend Yield % Chart
SHSE:603538 vs ZTS, UTHR: Dividend Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Ningbo Menovo Pharmaceutical Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ningbo Menovo Pharmaceutical Co Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ningbo Menovo Pharmaceutical Co's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Ningbo Menovo Pharmaceutical Co's Dividend Yield % falls into.
Ningbo Menovo Pharmaceutical Co (SHSE:603538) has a Dividend Yield % of 0.14% as of Jul. 02, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Ningbo Menovo Pharmaceutical Co and its competitors. This is 79% below median its historical median of 0.68. Over the past decade, Ningbo Menovo Pharmaceutical Co's Dividend Yield % has ranged from 0.08 to 1.48. According to the industry distribution chart, Ningbo Menovo Pharmaceutical Co ranks #495 out of 516 companies in the Drug Manufacturers industry, placing it in the top 95.9%.
Is Ningbo Menovo Pharmaceutical Co's Dividend Yield % too high?
Ningbo Menovo Pharmaceutical Co's current Dividend Yield % of 0.14% is 79% below median its 10-year median of 0.68. Over the past 10 years, this metric has ranged from a low of 0.08 to a high of 1.48. The Drug Manufacturers industry median Dividend Yield % is 1.97. Ningbo Menovo Pharmaceutical Co's value of 0.14% is 92.9% below this industry median. Based on the distribution chart, Ningbo Menovo Pharmaceutical Co ranks #495 out of 516 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Ningbo Menovo Pharmaceutical Co has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ningbo Menovo Pharmaceutical Co's Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Ningbo Menovo Pharmaceutical Co ranks #495 out of 516 companies for Dividend Yield %. This places Ningbo Menovo Pharmaceutical Co in the lower half of its industry. The industry median Dividend Yield % is 1.97. Ningbo Menovo Pharmaceutical Co's value of 0.14% is 92.9% below this benchmark. Historically, Ningbo Menovo Pharmaceutical Co's own Dividend Yield % has ranged from 0.08 to 1.48 over the past decade. While the company's 10-year median is 0.68 vs. the industry median of 1.97, Ningbo Menovo Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 1.97, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ningbo Menovo Pharmaceutical Co's current Dividend Yield % of 0.14% is 92.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Ningbo Menovo Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 1.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ningbo Menovo Pharmaceutical Co's current Dividend Yield % is 0.14%, which is 79% below median its own 10-year median of 0.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ningbo Menovo Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Ningbo Menovo Pharmaceutical Co (SHSE:603538) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥22.23, compared to a current price of ¥39.39 — trading 77.2% above its estimated fair value. The current Dividend Yield % is 0.14%, which is 79% below median its 10-year median of 0.68 and 92.9% below the Drug Manufacturers industry median of 1.97. Ningbo Menovo Pharmaceutical Co's overall GF Score™ is 62/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Ningbo Menovo Pharmaceutical Co (SHSE:603538), the current Dividend Yield % is 0.14% as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ningbo Menovo Pharmaceutical Co (SHSE:603538) Overvalued in 2026?
Based on GuruFocus' analysis, Ningbo Menovo Pharmaceutical Co stock appears to be overvalued.
The current stock price of ¥39.39 is trading 77.2% above its estimated GF Value™ of ¥22.23.
GuruFocus considers Ningbo Menovo Pharmaceutical Co to be Significantly Overvalued.
Key valuation signals for SHSE:603538:
Dividend Yield %: 0.14% (79% below median its 10-year median of 0.68)
GF Value™: ¥22.23 vs. price of ¥39.39 (77.2% above fair value)
Industry Position: 92.9% below the Drug Manufacturers median (#495 of 516)
No single metric tells the full story. See the SHSE:603538 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ningbo Menovo Pharmaceutical Co Business Description
Ningbo Menovo Pharmaceutical Co Ltd is a China-based company is engaged in the research and development, pilot, production and sales of pharmaceutical intermediates, APIs and finished drugs. Its products line includes cardiovascular, central nervous, respiratory, anti-tumor, anti-infective, digestive system, geriatric diseases and anti-viral systems.
62GF Score
Get the complete analysis for SHSE:603538
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603538 has been successfully added to your 
